Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,730 GBX | -0.94% | -2.70% | +19.29% |
05-30 | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
05-30 | Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.29% | 90.55B | |
+39.82% | 731B | |
+31.34% | 586B | |
-7.31% | 348B | |
+14.23% | 319B | |
+0.86% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+4.51% | 159B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Bernstein Lifts GSK PT, Keeps Outperform Rating